Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update

被引：51
|
作者：
Ciarallo, Anthony [1 ]
Rivera, Juan [2 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med Imaging, Div Nucl Med, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] McGill Univ, Hlth Ctr, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2020年 / 215卷 / 02期
关键词：
differentiated thyroid cancer; DTC; I-131; radioactive iodine therapy; RAI; thyroid cancer; RADIOIODINE-REMNANT ABLATION; I-131; METAANALYSIS; PATIENT;
D O I：
10.2214/AJR.19.22626
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I-131 are appropriate for each risk category.
引用
收藏
页码：285 / 291
页数：7
相关论文
共 50 条
  • [1] Radioactive iodine therapy in poorly differentiated thyroid cancer
    Tuttle, R. Michael
    Grewal, Ravinder K.
    Larson, Steve M.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 665 - 668
  • [2] Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer
    Tiuca, Robert Aurelian
    Tiuca, Oana Mirela
    Pop, Raluca Monica
    Pascanu, Ionela Maria
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [3] Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer
    Verburg, Frederik A.
    Haenscheid, Heribert
    Luster, Markus
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 279 - 290
  • [4] Update on the systemic management of radioactive iodine refractory differentiated thyroid cancer (Review)
    Babu, Geethu
    Kainickal, Cessal Thommachan
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (02) : 1 - 7
  • [5] Radioactive iodine in differentiated thyroid cancer: a national database perspective
    Orosco, Ryan K.
    Hussain, Timon
    Noel, Julia E.
    Chang, David C.
    Dosiou, Chrysoula
    Mittra, Erik
    Divi, Vasu
    Orloff, Lisa A.
    ENDOCRINE-RELATED CANCER, 2019, 26 (10) : 795 - 802
  • [6] Chapter 7: Radioactive Iodine Treatment in Differentiated Thyroid Cancer
    Agrawal, Archi
    Dhar, Harsh
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2024, 12 (SUPPL 1): : S36 - S42
  • [7] Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer
    Wang, Sen
    Liang, Chao
    Zhao, Li
    Meng, Zhaowei
    Zhang, Chunmei
    Jia, Qiang
    Tan, Jian
    Yang, Hui
    Liu, Xiangxiang
    Wang, Xiaoran
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1113 - 1120
  • [8] Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer
    Hong C.M.
    Ahn B.-C.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (4) : 247 - 253
  • [9] Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Cortas, Christos
    Charalambous, Haris
    LIFE-BASEL, 2024, 14 (01):
  • [10] Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
    Toro-Tobon, David
    Morris, John C.
    Hilger, Crystal
    Peskey, Candy
    Durski, Jolanta M.
    Ryder, Mabel
    THYROID, 2024, 34 (01) : 70 - 81
12345